DOP2009000083A - Composiciones y metodos para modular recpetores de pdgfr y c-kit - Google Patents
Composiciones y metodos para modular recpetores de pdgfr y c-kitInfo
- Publication number
- DOP2009000083A DOP2009000083A DO2009000083A DO2009000083A DOP2009000083A DO P2009000083 A DOP2009000083 A DO P2009000083A DO 2009000083 A DO2009000083 A DO 2009000083A DO 2009000083 A DO2009000083 A DO 2009000083A DO P2009000083 A DOP2009000083 A DO P2009000083A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- methods
- raf
- pdgfr
- compounds
- kit
- Prior art date
Links
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 title abstract 2
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 abstract 1
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 abstract 1
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 abstract 1
- 101100127166 Escherichia coli (strain K12) kefB gene Proteins 0.000 abstract 1
- 101150036586 FES gene Proteins 0.000 abstract 1
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 abstract 1
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 abstract 1
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 abstract 1
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 abstract 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 abstract 1
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 abstract 1
- 101000606502 Homo sapiens Protein-tyrosine kinase 6 Proteins 0.000 abstract 1
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 abstract 1
- 101000922131 Homo sapiens Tyrosine-protein kinase CSK Proteins 0.000 abstract 1
- 101150028321 Lck gene Proteins 0.000 abstract 1
- 108700036166 Mitogen-Activated Protein Kinase 11 Proteins 0.000 abstract 1
- 102100026929 Mitogen-activated protein kinase 11 Human genes 0.000 abstract 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 abstract 1
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 abstract 1
- 101150038994 PDGFRA gene Proteins 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 102100039810 Protein-tyrosine kinase 6 Human genes 0.000 abstract 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 abstract 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 abstract 1
- 108010029869 Proto-Oncogene Proteins c-raf Proteins 0.000 abstract 1
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 abstract 1
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 abstract 1
- 108060006706 SRC Proteins 0.000 abstract 1
- 101001045447 Synechocystis sp. (strain PCC 6803 / Kazusa) Sensor histidine kinase Hik2 Proteins 0.000 abstract 1
- 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 abstract 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 abstract 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 abstract 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 abstract 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 abstract 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 abstract 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 239000003909 protein kinase inhibitor Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención proporciona compuestos y composiciones farmacéuticas del mismo que utiles como inhibidores de proteina cinasa, así como lo métodos para usar dichos compuestos para tratar, aliviar o prevenir una condición asociada con la actividad normal o no reguilada de la cinasa. En algunas realizaciones, la invención proporciona m?0todos para utilizar dichos compuestos para tratar, aliviar o prevenir enfermedades o tratornos que involucran la actividad anormal de las cinasas c-kit, PDGFRa, PDGFR B, CSF IR, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGF B, SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2b, BRK, KDR, c-raf o b-raf, o formas mutantes de las mismas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2009000083A DOP2009000083A (es) | 2009-04-20 | 2009-04-20 | Composiciones y metodos para modular recpetores de pdgfr y c-kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2009000083A DOP2009000083A (es) | 2009-04-20 | 2009-04-20 | Composiciones y metodos para modular recpetores de pdgfr y c-kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2009000083A true DOP2009000083A (es) | 2009-06-30 |
Family
ID=44680871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2009000083A DOP2009000083A (es) | 2009-04-20 | 2009-04-20 | Composiciones y metodos para modular recpetores de pdgfr y c-kit |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2009000083A (es) |
-
2009
- 2009-04-20 DO DO2009000083A patent/DOP2009000083A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP099353A (es) | Composiciones y métodos para modular los receptores | |
| BRPI0815572A2 (pt) | Compostos e composições como inibidores de quinases | |
| TN2010000087A1 (en) | 5-(4- haloalkoxy) phenyl pyrimidine -2- aminecompounds and compositons as kinase inhibitors | |
| EA200901654A1 (ru) | Ингибиторы и способы с их использованием | |
| PL2027123T3 (pl) | Związki i kompozycje jako inhibitory kinaz białkowych | |
| EA201000003A1 (ru) | Ингибиторы протеинкиназ и способы их применения | |
| WO2005034869A3 (en) | Compounds and compositions as protein kinase inhibitors | |
| TNSN06406A1 (en) | Compounds and compositions as protein kinase inhibitors | |
| WO2006124731A3 (en) | Compounds and compositions as protein kinase inhibitors | |
| TW200637547A (en) | Compounds and compositions as protein kinase inhibitors | |
| MX2007005547A (es) | Compuestos y composiciones como inhibidores de la proteina cinasa. | |
| PH12014500372A1 (en) | Compounds and compositions as c-kit kinase inhibitors | |
| PH12015501370A1 (en) | Compounds and methods for kinase modulation, and indications therefor | |
| UY31821A (es) | Compuestos y composiciones como inhibidores de quinasa | |
| CU20140023A7 (es) | DERIVADOS DE N-(3-(1,2,4-OXADIAZOL-3/5-IL)FENIL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA QUINASA c-Kit | |
| MY167575A (en) | Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases | |
| EA201790962A1 (ru) | Терапевтические соединения и связанные с ними способы применения | |
| DE602006014540D1 (en) | Pyrrolopyridinderivate als proteinkinaseinhibitoren | |
| WO2011090738A3 (en) | Type ii raf kinase inhibitors | |
| MY148468A (en) | Compounds and methods for kinase modulation, and indications therefor | |
| UA97816C2 (en) | Compounds modulating c-kit and/or c-fms activity and use thereof | |
| MX2009011951A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
| EA201490542A1 (ru) | Соединения и композиции в качестве pdgfr киназных ингибиторов | |
| EA201992135A1 (ru) | Стволовые клетки и клетки поджелудочной железы, используемые для лечения инсулинозависимого сахарного диабета | |
| MX2010001813A (es) | Metodos y composiciones para el tratamiento de canceres. |